Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.
Saved in:
| Title: | Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. |
|---|---|
| Authors: | Zhang, Jian1,2 (AUTHOR) syner2000@163.com, Meng, Yanchun1,2 (AUTHOR), Wang, Biyun1,2 (AUTHOR), Wu, Xinhong3 (AUTHOR), Zheng, Hongmei3 (AUTHOR), Hu, Jing4 (AUTHOR), Liu, Wei4 (AUTHOR), Chen, Wenyan5 (AUTHOR), Wang, Leiping1,2 (AUTHOR), Cao, Jun1,2 (AUTHOR), Tao, Zhonghua1,2 (AUTHOR), Li, Ting1,2 (AUTHOR), Ni, Sujie6 (AUTHOR), Yu, Zhengyan7 (AUTHOR), Sun, Lichun4 (AUTHOR), Wang, Yun5 (AUTHOR), Peng, Qiang5 (AUTHOR), Wang, Song7 (AUTHOR), Hu, Xin8 (AUTHOR), Wang, Jianfei9 (AUTHOR) |
| Source: | PLoS Medicine. 7/31/2025, Vol. 22 Issue 7, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15491277 |
|---|---|
| DOI: | 10.1371/journal.pmed.1004669 |
